title: Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo.
abstract: The intracellular metabolism of receptor-targeted 153Gd-DTPA-glycoproteins was studied in vitro and in vivo. These agents bound to cell surface receptors, underwent receptor mediated endocytosis, and were rapidly degraded to a metabolite which co-migrated with a 153Gd-DTPA-lysine standard on thin layer chromatography. The rates of dissociation of 153Gd and 111In from a glycoprotein-chelate conjugate were determined in vitro. Gadolinium readily dissociated, in a pH-sensitive manner, from glycoprotein-DTPA, and to a lesser degree glycoprotein-MX-DTPA. The biodistribution of targeted and blood pool 153Gd/111In labeled proteins also suggested that gadolinium dissociates from protein-DTPA and protein-MX-DTPA and their metabolites leading to an accumulation of gadolinium in bone. Metal-DTPA-glycoprotein agents targeted to cell surface receptors can still produce very high concentrations of radioactive or paramagnetic metals within the lysosome due to the high rate of accumulation afforded by receptor mediated endocytosis and the low release rate of metabolites such as metal-DTPA-lysine. However, the continued development of gadolinium based macromolecular agents will require improvements in bifunctional chelates.
authors.affiliation: Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
authors.forename: F N
authors.initials: FN
authors.lastname: Franano
authors.forename: W B
authors.initials: WB
authors.lastname: Edwards
authors.forename: M J
authors.initials: MJ
authors.lastname: Welch
authors.forename: M W
authors.initials: MW
authors.lastname: Brechbiel
authors.forename: O A
authors.initials: OA
authors.lastname: Gansow
authors.forename: J R
authors.initials: JR
authors.lastname: Duncan
mesh_terms: D000818:Animals; D002614:Chelating Agents / Q000493:pharmacokinetics; D003287:Contrast Media / Q000493:pharmacokinetics*; D005260:Female; D005682:Gadolinium / Q000493:pharmacokinetics*; D019786:Gadolinium DTPA; D006023:Glycoproteins / Q000493:pharmacokinetics*; D006801:Humans; D066298:In Vitro Techniques; D007205:Indium Radioisotopes; D009942:Organometallic Compounds / Q000493:pharmacokinetics; D004369:Pentetic Acid / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D011868:Radioisotopes; D051381:Rats; D017207:Rats, Sprague-Dawley; D014018:Tissue Distribution; D014407:Tumor Cells, Cultured
chemical_list: D002614:Chelating Agents; D003287:Contrast Media; D006023:Glycoproteins; D007205:Indium Radioisotopes; D009942:Organometallic Compounds; D011868:Radioisotopes; C077295:2-(4-isothiocyanatobenzyl)-6-methyldiethylenetriaminepentaacetic acid; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA